Sumitovant is a technology-driven biopharmaceutical company accelerating development and commercialization of novel therapies for patients with rare conditions and other diseases. Through our proprietary computing and data platforms, scientific expertise and diverse company portfolio, Sumitovant has supported development of multiple FDA-approved products and a robust pipeline of early-through late-stage investigational assets addressing unmet need in pediatrics, urology, oncology, women’s health, specialty respiratory and infectious diseases. Sumitovant is a wholly owned subsidiary of Sumitomo Pharma. Please visit our website sumitovant.com for more information on Sumitovant and our portfolio.
Driven by a patient-first mindset, we connect technology and life-sciences expertise to propel patient-needed therapies sooner.
Sumitovant is greater than the sum of our parts.
We're a global and diverse team. We are problem-solvers, engineers, scientists, technologists, innovators, and thought-leaders who value each other’s unique specialties and foster collaboration and connection across the world in support of our mission.
We embrace individuality while cultivating collaboration, creativity, and agility.
We care about the needs of our employees and appreciate the varied ways in which people do their best work individually and together.
Sumitovant is committed to supporting our employees.
Our benefits include:
Competitive Compensation – In addition to a base salary, all employees are eligible for an annual bonus and long-term incentive plan.
Unlimited Vacation – Flexible time off policy allows employees to take time away as needed.
Hybrid and Remote – Work arrangements options (role and team dependent).
Sabbatical Program – Employees are eligible for a 4-week sabbatical after completing four years of service.
At Sumitovant, we’re changing lives for the better with talented individuals who share our passion to change the world. We work to build an inclusive environment where everyone can do their best work.